Hemp Manufacturer Hempacco Prices Downsized US$6 Million IPO

Hemp manufacturing company Hempacco Co., Inc. (Nasdaq: HPCO) started trading its shares on the Nasdaq Capital Market on Tuesday. The initial public offering is estimated to gross US$6 million.

The offering consists of 1.0 million common shares, initially set at 3.0 million, selling at US$6.00 per share. The company is set to trade on the Nasdaq market under the symbol “HPCO”.

Boustead Securities acts as the sole bookrunner for the said offering, which is slated to close on September 1, 2022, subject to customary closing conditions.

The California-based firm makes CBD and hemp-based cigarettes, offering smokers a non-nicotine and tobacco alternative. The company aims to take on the US$1 trillion tobacco industry with its portfolio, including its own The Real Stuff functional hemp cigarette and rolling paper brand.


Information for this briefing was found via Edgar, Investment U, and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Isn’t In A Bubble, Currency Is. – Doug Casey

The Real Move Begins When They Cut Rates | Peter Krauth

Is Altamira Gold Sitting On Brazil’s Next Big Gold Discovery?

Recommended

Stifel Initiates Coverage On Goliath Resources With $5.00 Price Target

ESGold Completes Mill Building Construction, Final Equipment Procurement Underway

Related News

Biotech Firm HilleVax Prices US$200 Million IPO

Biopharmaceutical company HilleVax, Inc. (Nasdaq: HLVX) began trading on the Nasdaq Global Select Market on...

Monday, May 2, 2022, 02:25:00 PM

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM

Mining SPAC Rigel Resource Acquisition Prices US$275 Million IPO

Blank check company Rigel Resource Acquisition Corp. (NYSE: RRAC.U) went public yesterday on the New...

Saturday, November 6, 2021, 02:58:00 PM

Health SPAC CHW Acquisition Upsizes IPO To US$110 Million

Special purpose acquisition company CHW Acquisition Corporation (Nasdaq: CHWAU) went public on the Nasdaq Capital...

Wednesday, September 1, 2021, 11:19:00 AM